Q1 2019 Catabasis Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q1 Catabasis Pharmaceuticals Inc., Earnings Conference Call. (Operator Instructions) As a reminder, this call may be recorded.
I would now like to introduce your host for today's conference, Andrea Matthews. Please go ahead.
Thank you, Chris. Welcome to today's Catabasis Pharmaceuticals conference call, where we will provide a corporate update and review our first quarter 2019 financial results.
With me today are Jill Milne, Chief Executive Officer; Joanne Donovan, Chief Medical Officer; Andrew Nichols, Chief Scientific Officer; and Noah Clauser, Vice President of Finance.
We issued a press release this morning summarizing our corporate update and our Q1 2019 financial results, which we'll reference on today's call and is available on our website.
I would like to note that during today's call, we will make statements related to our business based on current and future expectations that may be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |